Clinical studies recruiting near Stony Brook

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Stony Brook University Hospital · Joseph Broderick, MD · NCT07227246 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Stony Brook University Medical Center · National Cancer Institute (NCI) · NCT05564390 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Stony Brook University Medical Center · NRG Oncology · NCT05624996 Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Phase 1/Phase 2 · 5040, SUNY Stony Brook Clinical Research Site · National Institute of Allergy and Infectious Diseases (NIAID · NCT02140255 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Stony Brook University Medical Center · National Cancer Institute (NCI) · NCT05691478 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Stony Brook University · Eli Lilly and Company · NCT07415044 StrokeNet Thrombectomy Endovascular Platform
NA · Stony Brook University Hospital · Medical University of South Carolina · NCT06289985 Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck
NA · Stony Brook University Medical Center · Rijnstate Hospital · NCT05484115 A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With
Phase 2 · Stony Brook Cancer Center · Biostar Pharma, Inc. · NCT06764940 Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
NA · Laufer Center for Physical and Quantitative Biology , Stony · Stony Brook University · NCT06373016 Quality of Pediatric Resuscitation in a Multicenter Collaborative
Phase N/A · Stony Brook University Hospital · Children's Hospital of Philadelphia · NCT02708134 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Stony Brook University Hospital · Regeneron Pharmaceuticals · NCT06091865 Raman Spectroscopy and Skin Cancer
Phase N/A · Stony Brook Hospital · Tiezhi Zhang · NCT06384924 The Role of mGluR5 in CBT-I
Phase 4 · Stony Brook University: Dept of Psychiatry · Stony Brook University · NCT07076342 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Stony Brook University Medical Center · Children's Oncology Group · NCT04322318 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Stony Brook University-Cancer Center ( Site 0072) · Merck Sharp & Dohme LLC · NCT06077760 Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · SWOG Cancer Research Network · NCT06769126 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Stony Brook University Medical Center · NRG Oncology · NCT05946213 Nectero EAST System Clinical Study
Phase 2/Phase 3 · Stony Brook Medicine · Nectero Medical, Inc. · NCT06001918 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · NRG Oncology · NCT06532279 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Stony Brook University Medical Center · NRG Oncology · NCT05174169 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Stony Brook University Medical Center · Alliance for Clinical Trials in Oncology · NCT06931340 A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax,
Phase 1 · Stony Brook University Hospital · Kura Oncology, Inc. · NCT05735184 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Stony Brook University Medical Center · Alliance for Clinical Trials in Oncology · NCT06876714 Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
NA · Stony Brook Heart Institute · Innoventric LTD · NCT06212193 PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.
Phase 4 · Stony Brook University: Dept of Psychiatry · Stony Brook University · NCT07095205 TaVNS for Delirium
NA · Stony Brook University Hospital · Stony Brook University · NCT07258082 Controlled Trial of Hydrogen Water as a Treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
NA · Stony Brook University · Fred Friedberg · NCT07753122 A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · Stony Brook University Medical Center · Children's Oncology Group · NCT04293562 The VENTOR Clinical Study
NA · Stony Brook University Hospital · CoLabs Medical · NCT06759389

Look up another city

Look up another condition